循環器ジャーナル68巻3号

2020年07月発行

特集 不整脈治療の最新デバイステクノロジーとリードマネジメント Ⅱ．除細動治療

皮下植込み型除細動器（subcutaneous implantable defibrillator;S-ICD）

著者： 岡田綾子¹

所属機関： ¹信州大学医学部附属病院循環器内科

ページ範囲：P.452 - P.458

Point
・S-ICDデバイスは完全な皮下植込み型の電気的除細動器である．
・静脈アクセスや易感染性，若年者に対するTV-ICDの問題がこのデバイスの登場により解決された．
・ペーシング機能や抗頻拍ペーシング機能が付随していないが，必要である症例を除外することで適切なデバイス選択が可能となる．

参考文献

1) Theuns DA, Crozier IG, Barr CS, et al:Longevity of the Subcutaneous Implantable Defibrillator:Long-Term Follow-Up of the European Regulatory Trial Cohort. Circ Arrhythm Electrophysiol 8:1159-1163, 2015

2) Honarbakhsh S, Providencia R, Srinivasan N, et al:A propensity matched case-control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. Int J Cardiol 228:280-285, 2017

3) Quast ABE, Brouwer TF, Tjong FVY, et al:Clinical parameters to optimize patient selection for subcutaneous and transvenous implantable defibrillator therapy. Pacing Clin Electrophysiol 41:990-995, 2018

4) Boersma L, Barr C, Knops R, et al:Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry:The EFFORTLESS Study. J Am Coll Cardiol 70:830-841, 2017

5) El-Chami MF, Levy M, Kelli HM, et al:Outcome of Subcutaneous Implantable Cardioverter Defibrillator Implantation in Patients with End-Stage Renal Disease on Dialysis. J Cardiovasc Electrophysiol 26:900-904, 2015

6) Koman E, Gupta A, Subzposh F, et al:Outcomes of subcutaneous implantable cardioverter-defibrillator implantation in patients on hemodialysis. J Interv Card Electrophysiol 45:219-223, 2016

7) Tjong FVY, Brouwer TF, Kooiman KM, et al:Communicating Antitachycardia Pacing-Enabled Leadless Pacemaker and Subcutaneous Implantable Defibrillator. J Am Coll Cardiol 67:1865-1866, 2016

8) Tjong FVY, Brouwer TF, Koop B, et al:Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator. JACC Clin Electrophysiol 3:1487-1498, 2017

9) Okamura H, McLeod CJ, DeSimone CV, et al:Right Parasternal Lead Placement Increases Eligibility for Subcutaneous Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease. Circ J 80:1328-1335, 2016

10) Alonso P, Osca J, Cano O, et al:The Role of Conventional and Right-Sided ECG Screening for Subcutaneous ICD in a Tetralogy of Fallot Population. Pacing Clin Electrophysiol 40:145-153, 2017

11) Winter J, Siekiera M, Shin DI, et al:Intermuscular technique for implantation of the subcutaneous implantable cardioverter defibrillator:long-term performance and complications. Europace 19:2036-2041, 2017

12) Taguchi Y, Ishikawa T, Matsumoto K, et al:An Inappropriate Shock Case Early after Implantation of a Subcutaneous Cardiac Defibrillator by Subcutaneous Entrapped Air. Int Heart J 59:417-419, 2018

13) Knops RE, Olde Nordkamp LR, de Groot JR, et al:Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 10:1240-1243, 2013

14) Theuns DAMJ, Brouwer TF, Jones PW, et al:Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator. Heart Rhythm 15:1515-1522, 2018

15) Pettit SJ, McLean A, Colquhoun I, et al:Clinical experience of subcutaneous and transvenous implantable cardioverter defibrillators in children and teenagers. Pacing Clin Electrophysiol 36:1532-1538, 2013

16) Jarman JW, Lascelles K, Wong T, et al:Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults:cause for caution. Eur Heart J 33:1351-1359, 2012

17) McLeod KA, McLean A:Implantation of a fully subcutaneous ICD in children. Pacing Clin Electrophysiol 35:e20-e23, 2012

18) García-Riesco L, Pedrote A, Arana-Rueda E, et al:Totally subcutaneous implantable cardioverter-defibrillator in a child with complex congenital heart disease and infection in a previous transvenous system. Rev Esp Cardiol（Engl Ed）67:961-962, 2014

19) Montgomery JA, Orton JM, Ellis CR:Feasibility of Defibrillation and Pacing Without Transvenous Leads in a Combined MICRA and S-ICD System Following Lead Extraction. J Cardiovasc Electrophysiol 28:233-234, 2017

20) Viani S, Migliore F, Tola G, et al:Use and outcomes of subcutaneous implantable cardioverter-defibrillator（ICD）after transvenous ICD extraction:An analysis of current clinical practice and a comparison with transvenous ICD reimplantation. Heart Rhythm 16:564-571, 2019

21) 日本循環器学会，日本不整脈心電学会：不整脈非薬物治療ガイドライン（2018年改訂版）．2019